HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Edilia Tapia Selected Research

Febuxostat

4/2008Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia.
4/2008Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome.
1/2008Effect of febuxostat on the progression of renal disease in 5/6 nephrectomy rats with and without hyperuricemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Edilia Tapia Research Topics

Disease

27Hypertension (High Blood Pressure)
02/2021 - 10/2001
16Proteinuria
10/2018 - 10/2001
15Inflammation (Inflammations)
12/2023 - 03/2003
13Chronic Renal Insufficiency
02/2023 - 08/2013
13Hyperuricemia
02/2021 - 11/2002
10Mitochondrial Diseases (Mitochondrial Disease)
05/2019 - 08/2011
9Ischemia
01/2022 - 10/2003
8Fibrosis (Cirrhosis)
04/2023 - 10/2001
7Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2023 - 01/2007
6Dehydration (Water Stress)
01/2020 - 01/2016
5Diabetic Nephropathies (Diabetic Nephropathy)
11/2020 - 09/2013
5Acute Kidney Injury (Acute Renal Failure)
11/2020 - 01/2012
4Ureteral Obstruction
12/2023 - 07/2021
4Hypoxia (Hypoxemia)
04/2023 - 02/2017
4Neoplasms (Cancer)
09/2017 - 05/2012
4Renal Hypertension
01/2015 - 11/2007
3B-Cell Lymphoma (Lymphoma, B Cell)
12/2023 - 12/2013
3Hypertriglyceridemia
11/2022 - 01/2007
3Body Weight (Weight, Body)
02/2021 - 08/2011
3Hyperglycemia
02/2021 - 10/2018
3Glycosuria
10/2018 - 10/2014
2Hypertrophy
04/2023 - 01/2007
2Heart Diseases (Heart Disease)
04/2023 - 04/2015
2Cardiovascular Diseases (Cardiovascular Disease)
02/2023 - 05/2022
2Dyslipidemias (Dyslipidemia)
02/2023 - 11/2022
2Obesity
05/2022 - 02/2021
2Kidney Diseases (Kidney Disease)
02/2021 - 01/2016
2Necrosis
01/2020 - 01/2013
2Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy)
09/2017 - 03/2017
2Chronic Kidney Failure (Chronic Renal Failure)
09/2013 - 02/2013
2Atrophy
02/2013 - 06/2002
2Reperfusion Injury
01/2012 - 12/2011
2Sclerosis
01/2012 - 06/2002
1Bites and Stings (Sting)
11/2023
1Cardio-Renal Syndrome
08/2023

Drug/Important Bio-Agent (IBA)

18AntioxidantsIBA
12/2023 - 11/2005
16CurcuminIBA
11/2022 - 10/2011
11FructoseIBA
04/2023 - 01/2007
10CreatinineIBA
01/2020 - 11/2006
9EnzymesIBA
07/2021 - 11/2005
8Proteins (Proteins, Gene)FDA Link
11/2020 - 10/2003
8Oxonic AcidIBA
01/2018 - 11/2002
6sulforaphaneIBA
12/2023 - 08/2011
6Uric Acid (Urate)IBA
04/2023 - 01/2005
6fructokinaseIBA
04/2023 - 03/2013
5Cisplatin (Platino)FDA LinkGeneric
05/2019 - 08/2011
5Hexosaminidases (Hexosaminidase)IBA
10/2018 - 01/2012
5Glutathione PeroxidaseIBA
05/2018 - 08/2011
5Urate Oxidase (Uricase)IBA
01/2018 - 01/2005
5Urea (Carbamide)FDA LinkGeneric
09/2017 - 11/2007
5NitrogenIBA
09/2017 - 11/2007
5Mycophenolic Acid (Cellcept)FDA LinkGeneric
07/2016 - 11/2001
5Angiotensin IIIBA
01/2016 - 11/2001
5Oxidants (Oxidizing Agents)IBA
07/2013 - 08/2011
4Vasopressins (Vasopressin)IBA
05/2022 - 01/2016
4allicinIBA
11/2020 - 01/2016
4Potassium DichromateFDA Link
11/2020 - 11/2014
4Allopurinol (Remid)FDA LinkGeneric
01/2018 - 11/2002
4SaltsIBA
04/2013 - 11/2001
3Folic Acid (Vitamin M)FDA LinkGeneric
08/2023 - 01/2019
3Triglycerides (Triacylglycerol)IBA
04/2023 - 04/2008
3Therapeutic UsesIBA
11/2022 - 05/2012
3nephrinIBA
11/2020 - 01/2016
3Insulin (Novolin)FDA Link
11/2020 - 04/2008
3maleic acid (maleate)IBA
01/2020 - 11/2016
3Drinking WaterIBA
01/2015 - 01/2007
3Adenosine Triphosphate (ATP)IBA
01/2015 - 10/2011
3chromium hexavalent ionIBA
11/2014 - 10/2011
3SodiumIBA
10/2014 - 01/2005
3Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2008 - 11/2006
3FebuxostatFDA Link
04/2008 - 01/2008
3Xanthine OxidaseIBA
04/2008 - 01/2008
2InterleukinsIBA
12/2023 - 10/2018
2Transcription Factors (Transcription Factor)IBA
12/2023 - 11/2008
2NucleotidesIBA
12/2023 - 11/2023
2InflammasomesIBA
11/2023 - 01/2018
2osthol (osthole)IBA
04/2023 - 02/2021
2polyolIBA
05/2022 - 01/2020
2SugarsIBA
02/2021 - 01/2016
2Mitogen-Activated Protein Kinase 3IBA
01/2020 - 01/2019
2Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
11/2019 - 01/2017
2Losartan (Cozaar)FDA LinkGeneric
09/2017 - 06/2002
2Aldehyde Reductase (Aldose Reductase)IBA
01/2017 - 01/2016
2Glucose (Dextrose)FDA LinkGeneric
01/2016 - 03/2013
2tempolIBA
01/2015 - 10/2008
2salicylhydroxamic acid (SHAM)IBA
06/2011 - 12/2006
23-nitrotyrosineIBA
11/2008 - 11/2007
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
11/2008 - 11/2007
1Caspase 3 (Caspase-3)IBA
12/2023
1Adenosine Monophosphate (AMP)IBA
11/2023
1Toll-Like Receptors (Toll-Like Receptor)IBA
11/2023
1PyrinIBA
11/2023
1Guanosine Monophosphate (5' Guanylic Acid)IBA
11/2023
1InterferonsIBA
11/2023
1Leucine (L-Leucine)FDA Link
11/2023
1ChemokinesIBA
11/2023

Therapy/Procedure

10Nephrectomy
11/2022 - 10/2001
3Therapeutics
01/2016 - 12/2013
3Punctures
01/2005 - 06/2002
2Fluid Therapy (Oral Rehydration Therapy)
11/2019 - 01/2016